Pfizer (PFE)
(Delayed Data from NYSE)
$27.77 USD
-0.39 (-1.38%)
Updated May 7, 2024 04:00 PM ET
After-Market: $27.50 -0.27 (-0.97%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth B Momentum B VGM
Brokerage Reports
Pfizer Inc. [PFE]
Reports for Purchase
Showing records 141 - 160 ( 555 total )
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 8122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended July 22.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
No Life Science Worries - Positive Reads
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 72122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 71122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended July 1.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 7122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended June 24.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Battling Covid - Vaccines, Prescription Treatments, and Supplements from Alpha (Á) through Lambda (Ë)
Provider: Univest Securities, LLC
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 62122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
E.N.D.O - Exploring New Drug Opportunities in Endocrinology KOL Call Highlights
Provider: Wedbush Securities Inc.
Analyst: ARGYRIDES A
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 61122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended June 3.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 6122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended May 6.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for PFE.
Provider: Stock Traders Daily
Analyst: Research Department